Single-session attention training for Functional Cognitive Disorder
Official title: Feasibility Pilot Study of a Brief Intervention in Functional Cognitive Disorder
Run by King's College Hospital NHS Trust · NCT07379723 · Data updated 2026-11-12
This project will try a single-session attention-training intervention to see if it helps adults with Functional Cognitive Disorder have fewer symptoms and better daily functioning.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | King's College Hospital NHS Trust Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | November 11, 2025 |
| Main results expected | March 13, 2026 |
| Study ends | May 1, 2026 |
| Registry record updated | January 30, 2026 |
| Trial ID | NCT07379723 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 65 or younger with a clinical diagnosis of Functional Cognitive Disorder, normal MRI results, no neurological diagnosis, capacity to consent, and not enrolled in another intervention trial are ideal candidates.
✕Probably not a fit
People over 65, those with abnormal MRI or a neurological diagnosis, those with severe depression or lacking capacity to consent, and participants already in other intervention trials are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults meeting criteria for Functional Cognitive Disorder complete baseline questionnaires on cognitive concerns, mood, functional impairment, and quality of life, then attend a single clinic session to learn and practice the Attention Training Technique (ATT). Two scheduled telephone follow-ups collect the same questionnaires plus feedback about the intervention and study experience. The protocol is a feasibility pilot focused on acceptability, adherence, and preliminary signals of change in symptoms and function. Eligibility requires age 65 or below, a normal MRI, no neurological diagnosis, and capacity to consent.
Why it matters
Potential benefit: If successful, patients might experience reduced cognitive complaints and improved day-to-day functioning and quality of life after a brief, easily delivered intervention.
How similar studies have gone: Attention Training has shown promise in related conditions such as anxiety and functional neurological symptoms, but its use as a single-session intervention specifically for FCD is largely untested and exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 65 or below * Meet criteria for diagnosis of FCD (criteria include normal MRI results with no neurological diagnosis, and symptoms that are not explained by any other medical condition, performance at routine pre-baseline neuropsychological assessment within the service) * Not taking part in any other intervention study or trial Exclusion Criteria: * Aged above 65 years * Lack capacity to consent * MRI results not in normal range * Neurological diagnosis * Indication of severe low mood or depression (from clinical interview, routine measures) * Taking part in any other intervention study or trial
Where it's running
-
King's College Hospital
London, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lombardy Brain Health Services cohort
This project will see if a blood biomarker (pTau-217), together with clinical and cognitive tests, can help distinguish adults in Lombardy who have subjective cognitive decline, functional cognitive disorder, or are worried about their thinking.
-
Delirium and Light: Exploring Modifiable Risk Factors in Critically Ill Adults
This pilot observational study tests whether circadian-light factors influence delirium risk in adults recovering in critical care.
-
Automated oxygen control for preterm babies on non-invasive support
This trial tests whether closed-loop automated oxygen control helps preterm babies on non-invasive ventilation reach target oxygen levels more often and spend less time on supplemental oxygen compared with manual control.
-
Personalized miscarriage risk score: does sharing risk affect anxiety in early pregnancy?
This study tests whether giving a personalized miscarriage risk score to people under 12 weeks with a single ongoing pregnancy affects their anxiety.
-
Biodegradable stents for high-grade bile duct strictures in PSC
This study tests whether placing biodegradable stents helps open tight bile duct strictures in people with primary sclerosing cholangitis.
-
Good Boost+ for adults awaiting knee replacement
This feasibility trial tests whether a community-based prehabilitation program called Good Boost+ can be run with people waiting for a knee replacement and whether it could work in larger future studies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.